Table 2. The relative distribution and prevalence of cancer cases by type in the All of Us Research Program from self-reported survey data and electronic health record overall.

	EHR			Survey Data			EHR + Survey
	N	% dist	prevalence	N	% dist	prevalence	N	% dist	prevalence
Population			203,813			89,261			62,497
Total Cancers	23,520	-	11.54%	13,298	-	14.90%	7,123	-	11.40%
Bladder	983	4.18%	0.48%	483	3.63%	0.54%	301	4.23%	0.48%
Blood	4,841	20.58%	2.38%	1,113	8.37%	1.25%	657	9.22%	1.05%
Bone	350	1.49%	0.17%	181	1.36%	0.20%	107	1.50%	0.17%
Brain	612	2.60%	0.30%	182	1.37%	0.20%	102	1.43%	0.16%
Breast	6,474	27.53%	3.18%	4,062	30.55%	4.55%	2,499	35.08%	4.00%
Cervix	576	2.45%	0.28%	869	6.53%	0.97%	172	2.41%	0.28%
Colon & Rectum	2,601	11.06%	1.28%	722	5.43%	0.81%	385	5.41%	0.62%
Endocrine System	1,887	8.02%	0.93%	129	0.97%	0.14%	63	0.88%	0.10%
Endometrium	1,364	5.80%	0.67%	459	3.45%	0.51%	212	2.98%	0.34%
Esophagus	230	0.98%	0.11%	110	0.83%	0.12%	60	0.84%	0.10%
Eye	123	0.52%	0.06%	66	0.50%	0.07%	28	0.39%	0.04%
Head & Neck	1,698	7.22%	0.83%	333	2.50%	0.37%	155	2.18%	0.25%
Kidney	1,266	5.38%	0.62%	487	3.66%	0.55%	313	4.39%	0.50%
Lung	1,081	4.60%	0.53%	463	3.48%	0.52%	283	3.97%	0.45%
Ovary	786	3.34%	0.39%	348	2.62%	0.39%	207	2.91%	0.33%
Pancreas	548	2.33%	0.27%	119	0.89%	0.13%	77	1.08%	0.12%
Prostate	3,971	16.88%	1.95%	2,165	16.28%	2.43%	1,304	18.31%	2.09%
Stomach	320	1.36%	0.16%	76	0.57%	0.09%	35	0.49%	0.06%
Thyroid	1,648	7.01%	0.81%	924	6.95%	1.04%	573	8.04%	0.92%

*Skin cancer is excluded from the analysis as it is not differentiated as malignant/non-malignant/melanoma in AoU survey.